1
|
Aranda J, Oriol I, Feria L, Abelenda G, Rombauts A, Simonetti AF, Catalano C, Pallarès N, Martín M, Vàzquez N, Vall-Llosera E, Rhyman N, Suárez RC, Nogué M, Loureiro-Amigo J, Coloma A, Ceresuela L, Carratalà J. Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study. PLoS One 2022; 17:e0275615. [PMID: 36215250 PMCID: PMC9550043 DOI: 10.1371/journal.pone.0275615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 09/20/2022] [Indexed: 11/07/2022] Open
Abstract
OBJECTIVE To determine the health status and exercise capacity of COVID-19 survivors one year after hospital discharge. METHODS This multicenter prospective study included COVID-19 survivors 12 months after hospital discharge. Participants were randomly selected from a large cohort of COVID-19 patients who had been hospitalized until 15th April 2020. They were interviewed about persistent symptoms, underwent a physical examination, chest X-ray, and a 6-minute walk test (6MWT). A multivariate analysis was performed to determine the risk factors for persistent dyspnea. RESULTS Of the 150 patients included, 58% were male and the median age was 63 (IQR 54-72) years. About 82% reported ≥1 symptoms and 45% had not recovered their physical health. The multivariate regression analysis revealed that the female sex, chronic obstructive pulmonary disease, and smoking were independent risk factors for persistent dyspnea. Approximately 50% completed less than 80% of the theoretical distance on the 6MWT. Only 14% had an abnormal X-ray, showing mainly interstitial infiltrates. A third of them had been followed up in outpatient clinics and 6% had undergone physical rehabilitation. CONCLUSION Despite the high rate of survivors of the first wave of the COVID-19 pandemic with persistent symptomatology at 12 months, the follow-up and rehabilitation of these patients has been really poor. Studies focusing on the role of smoking in the persistence of COVID-19 symptoms are lacking.
Collapse
Affiliation(s)
- Judit Aranda
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Isabel Oriol
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
- Bellvitge Biomedical Research Institute (IDIBELL); L’Hospitalet de Llobregat, Barcelona, Spain
- Faculty of Medicine and Health Sciences, Clinical Science Department, University of Barcelona, Barcelona, Spain
| | - Lucía Feria
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Gabriela Abelenda
- Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
| | - Alexander Rombauts
- Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
| | | | | | - Natàlia Pallarès
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC; CB21/13/00009), Instituto de Salud Carlos III, Madrid, Spain
| | - Miguel Martín
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Núria Vàzquez
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Estel Vall-Llosera
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Nicolás Rhyman
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | | | - Marta Nogué
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Jose Loureiro-Amigo
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Ana Coloma
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Luis Ceresuela
- Consorci Sanitari Integral—Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain
| | - Jordi Carratalà
- Bellvitge Biomedical Research Institute (IDIBELL); L’Hospitalet de Llobregat, Barcelona, Spain
- Faculty of Medicine and Health Sciences, Clinical Science Department, University of Barcelona, Barcelona, Spain
- Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC; CB21/13/00009), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|